UPDATE 1: 11:47 p.m. ET 6/8/2021: Yestar Healthcare Holdings, in various
announcements to the Hong Kong stock exchange, disclosed that it had bought back 2.2 million shares in aggregate from May 20 to June 8 for a total consideration of HKD 2.5 million ($0.3 million), which implies an average price of HKD 1.16, according to Reorg’s calculations.
This brings the total amount of shares bought back by Yestar between the start of 2021 and June 8 to 8.2 million shares, with the company paying a total consideration of HKD 9.4 million -- which implies an average price of HKD 1.16.
Details of the share repurchase transactions are as follows:
Original Story 11:04 p.m. UTC on May 18, 2021Yestar Repurchased 6M Shares From April 8 to May 14 For HK$7M, Average Price of HK$1.16Relevant Document:FY’21 Share Buyback Announcements
Yestar Healthcare Holdings, in various announcements to the Hong Kong stock exchange, disclosed that it had bought back 5.97 million shares in aggregate from April 8 to May 14 for a total consideration of HK$6.9 million ($0.9 million), which implies an average price of HK$1.16.
Based on Reorg’s calculations, the amount of shares repurchased represented 0.25% of the company’s 2.35 billion total shares outstanding, after the cancellation of the shares repurchased.
Details of the share repurchase transactions are as follows:
According to the full-year 2020 annual report, the company repurchased 15.6 million shares for an aggregate consideration of HK$19.3 million - at an implied average price of HK$1.24 - with details as follows:
Reorg’s
Tear Sheet highlights that 217.5 million shares beneficially owned by Chairman and CEO, James Hartono, remain pledged to a financial institution to secure a loan granted to Hartono.